Impact of medical therapy on patients with Crohn&rsquo;s disease requiring surgical resection

doi:10.3748/wjg.v20.i33.11808

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 33

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5223)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

294

WORD

202

HTML

2386

Figures (1-2)

154

Tables (1-2)

115

Sum=3151

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1102

Download

970

Sum=2072

Sep 7, 2014 (publication date) through Jul 27, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Sep 7, 2014; 20(33): 11808-11814
Published online Sep 7, 2014. doi: 10.3748/wjg.v20.i33.11808

Full Size Figure Download Figure

Figure 1 Patients treated with anti-tumor necrosis factor agents had significantly longer median time from Crohn’s disease diagnosis to surgery. TNF: Tumor necrosis factor.

Citation: Fu YN, Hong T, Round A, Bressler B. Impact of medical therapy on patients with Crohn’s disease requiring surgical resection. World J Gastroenterol 2014; 20(33): 11808-11814
URL: https://www.wjgnet.com/1007-9327/full/v20/i33/11808.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i33.11808